Cash flow break even in the 2nd quarter of FY 18 is the word. Selling has been coming for the US apparently. Looks like it's nearly done.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025